![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/otello.jpg)
Transactions
Filter
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/otello.jpg)
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/q-linea.jpg)
Private placement of shares in Q-linea AB (SE) — SEK 151.5 million
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/olearys.jpg)
Acquisition of a minority stake in O’Learys (SE) by Altor Fund IV (SE) — Amount not disclosed
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/bygghemma-group.jpg)
Initial public offering of Bygghemma Group First AB (SE) on Nasdaq Stockholm — SEK 1.6 billion
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/altia.jpg)
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/Republic-of-Finland.jpg)
Initial public offering and listing of Altia Plc (FI) on the Main List of Nasdaq Helsinki — EUR 174 million
Senior secured bond issue by Aspire Global plc (MT) — EUR 27.5 million
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/next.jpg)
Directed new share issue in NEXT Biometrics Group ASA (NO) — NOK 120 million
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/oncopeptides.jpg)
Directed new share issue in Oncopeptides AB (SE) — SEK 314 million
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/elkem-2.jpg)
Initial public offering of Elkem ASA (NO) on the Oslo Stock Exchange — NOK 7.4 billion
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/np3-512x163.jpg)
Rights issue of preference shares in NP3 Fastigheter AB (SE) — SEK 288 million
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/norwegian-air-shuttle.jpg)
Directed new share issue in Norwegian Air Shuttle ASA (NO) — NOK 1.3 billion
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/moment-group.jpg)